Loading
Life sciences · Journal article
Synthetic and Systems Biotechnology · September 15, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Harmful cyanobacterial blooms (HCBs) are a prominent worldwide environmental concern. Proliferation of HCBs outpaces the development of mitigation and management technologies. Recently, cyanophages began to emerge as a potential abundant resource that can be harnessed for target-specific HCB treatment. However, there exist two major technical barriers in applying cyanophage-based treatment to HCB mitigation: host specificity and lysogenic life cycle. This minireview attempts to parse documented studies that developed or applied genetic engineering approaches or technologies to tackle the barriers through expanding host range and bypassing or abolishing the lysogenic life stage. We summarized representative technical approaches that may be extrapolated from bacteriophage to cyanophage, discussed genes and pathways that regulate host binding and infection or determine the switch between lytic and lysogenic lifecycles, identified existing knowledge and technological gaps and challenges, and proposed some attainable solutions and future perspectives for this fast-growing field of engineered cyanophage-mediated HCB remediation.